Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Easy Boba Introduces Limited-Edition ‘Cheese Foam Shakes’ — A Creamy Twist to Classic Flavours Press Release
  • ERPCA practice management software adds WhatsApp integration for improved client communication Technology
  • A monumental gathering that successfully convened influential figures from across the globe Business
  • NMIA Opens with Bharat’s Bravest at the Centre: Param Vir Chakra Awardees Part of Inaugural Celebration National
  • There is no season as best as off-season to go on an Adventure! ~Adventurers Lifestyle
  • RGIPT Welcomes New Batch at Orientation Programme 2026 Lifestyle
  • Why Pepperfry Is a Convenient Destination for Sofa Set Shopping Business
  • Kaushalya Logistics Expands Cement Supply Chain Footprint with Three New Depots in Uttar Pradesh Business

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Same Treatment, Different Price: Why Does Laser Hair Reduction Cost Vary Between Clinics? Health
  • Smt S R Mehta and Sir K P Cardiac Institute (Kikabhai Hospital) celebrated Silver Jubilee with felicitation of 15 Doctors and Distinguished Persons Health
  • Meadbery steps in to promote plant-based supplements for a better health Health
  • Allen Homoeopathy: Today, every 5 seconds, Allen’s Medicine is sold or dispensed in India Health
  • From India to the World: Naman Gosalia and AnginaX Are Taking Cardiovascular Prevention to the Global Stage Health
  • India’s Premier Integrative Oncology Specialist: Dr. Sandeep Roy Health

Recent Posts

  • Western H.O.G. Ride 2026 Concludes In Daman After A Weekend Of Riding, Brotherhood & Unforgettable Experiences
  • DMRC Wins HR for the Greater Good 2026 Award at XLRI’s HR for the Greater Good Conclave 2.0
  • Aetram’s All-in-One Online Trading App Empowers Modern Investors and Active Traders
  • Best Crypto Presale of 2026: AlphaPepe AI DEX Utility Leaves Rival Meme Coins Behind as USD 2.6M Milestone Sparks FOMO
  • How Laburnum Developers Is Setting New Benchmarks in Gurugram’s Premium Housing Market

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Red Chief expands into the Sports Shoes category with a focus on fashion and lifestyle range Business
  • HTL International Drives Sustainable Living Through Thoughtful Design, Circular Innovation and Responsible Manufacturing Business
  • Saket Group launches biggest luxury township project in Kalyan – SAKET WORLD Business
  • Arise Point Private Limited Emerges as One of India’s Most Recognised Names in Online Reputation Management and Strategic PR Business
  • Kotyark Industries Limited reports H2 & FY22 results Business
  • Concord Control Systems Limited Acquires Majority Stake in Advanced Rail Controls Private Limited Business
  • Senco Gold & Diamonds Partners With Olocker to Give Customers Free Jewellery Insurance, Letting Precious Memories Be Worn, Not Hidden Away Business
  • A boost for Indian Civil Engineering Industry: The Sandeep Pingale Model Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme